861 related articles for article (PubMed ID: 9209780)
1. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
2. In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC.
Deguchi T; Yasuda M; Ishihara S; Takahashi Y; Okezaki E; Nagata O; Saito I; Kawada Y
J Antimicrob Chemother; 1997 Sep; 40(3):437-9. PubMed ID: 9338500
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Shultz TR; Tapsall JW; White PA
Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
5. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Tanaka M; Tunoe H; Mochida O; Kanayama A; Saika T; Kobayashi I; Naito S
Diagn Microbiol Infect Dis; 2000 Oct; 38(2):109-13. PubMed ID: 11035242
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
Deguchi T; Yasuda M; Nakano M; Kanematsu E; Ozeki S; Ishihara S; Saito I; Kawada Y
J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
[TBL] [Abstract][Full Text] [Related]
8. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.
Tiejun Z; Xiaoming Z; Jilun Z; Yinghu Z; Yanhua R; Yue C; Weiming G; Tao Z; Qingwu J
Indian J Med Res; 2009 Jun; 129(6):701-6. PubMed ID: 19692753
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.
Barry AL; Fuchs PC
Antimicrob Agents Chemother; 1991 May; 35(5):955-60. PubMed ID: 1906696
[TBL] [Abstract][Full Text] [Related]
11. Detection of quinolone-resistant Neisseria gonorrhoeae.
Kam KM; Wong PW; Cheung MM; Ho NK
J Clin Microbiol; 1996 Jun; 34(6):1462-4. PubMed ID: 8735098
[TBL] [Abstract][Full Text] [Related]
12. Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
Erwin ME; Jones RN
J Clin Microbiol; 1992 May; 30(5):1170-3. PubMed ID: 1316366
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
[TBL] [Abstract][Full Text] [Related]
14. Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
Tanaka M; Nakayama H; Haraoka M; Nagafuji T; Saika T; Kobayashi I
Sex Transm Dis; 1998 Oct; 25(9):489-93. PubMed ID: 9800262
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
[TBL] [Abstract][Full Text] [Related]
16. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.
Tanaka M; Takahashi K; Saika T; Kobayashi I; Ueno T; Kumazawa J
J Urol; 1998 Jun; 159(6):2215-9. PubMed ID: 9598572
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results.
Jones RN; Barrett MS; Deguchi T
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):193-200. PubMed ID: 9327248
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
Su X; Lind I
Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
[TBL] [Abstract][Full Text] [Related]
19. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone treatment failure in gonorrhea. Emergence of a Neisseria gonorrhoeae strain with enhanced resistance to fluoroquinolones.
Deguchi T; Saito I; Tanaka M; Sato K; Deguchi K; Yasuda M; Nakano M; Nishino Y; Kanematsu E; Ozeki S; Kawada Y
Sex Transm Dis; 1997 May; 24(5):247-50. PubMed ID: 9153731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
